Kerala: Second case of Monkeypox found in India
18 July, 2022 | Vaishali Sharma
Union Health Ministry and National Center for Disease Control on Monday acknowledged that India has reported the second confirmed case of monkeypox from the Kannur region (NCDC).
Union Health Ministry and National Center for Disease Control on Monday acknowledged that India has reported the second confirmed case of monkeypox from the Kannur region (NCDC).
According to the Kerala Health Minister’s office, the virus has infected a 31-year-old man. The Pariyaram Medical College in Kannur is where he is receiving treatment.
“One more monkeypox confirmed in Kerala. The 31 year old man from Kannur is currently undergoing treatment at Pariyaram Medical College. The patient’s health condition is reported to be satisfactory,” said Kerala Health Minister Veena George.
The Union Health Ministry has already deployed the interdisciplinary central team of officials.
The minister also said that those who had frequent touch with him were being watched.
A traveller from Kerala who was travelling to the UAE was diagnosed with monkeypox earlier on July 14 in India.
New instructions for the treatment of the monkey pox sickness were announced by the Union Health Ministry on Friday. Avoiding contact with dead or wild animals was among the advice the Ministry gave the general populace to prevent the sickness (rodents, monkeys).
“No need to panic as Centre has given fresh directions to all the states and Union Territories regarding Monkeypox. It spreads through close contact with lesions, body fluids, prolonged contact with Respiratory Droplets and contaminated materials such as bedding,” said government sources.
Rajesh Bhushan, the secretary of health, referenced the letter the ministry wrote on May 31 in which it published its “Guidelines for Management of Monkeypox Disease.” As of right present, India has not recorded any cases of monkeypox.
The health secretary requested that all the states and union territories take important steps, such as regularly reminding and reorienting key stakeholders, such as health screening teams at points of entry (PoEs), disease surveillance teams, and hospital doctors, about common signs and symptoms, differential diagnoses, case definitions for suspect/probable/confirmed cases and contacts, contact tracing, and other surveillance activities that must be carried out for various diseases.